Assessing matrix, interferences and comparability between the Abbott Diagnostics and the Beckman Coulter high-sensitivity cardiac troponin I assays

Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I

(2018) Silvia Masotti et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial InfarctionClinical Perspective

(2016) Andrew R. Chapman et al.   CIRCULATION

Endogenous alkaline phosphatase interference in cardiac troponin I and other sensitive chemiluminescence immunoassays that use alkaline phosphatase activity for signal amplification

(2016) Daniel S. Herman et al.   CLINICAL BIOCHEMISTRY

Matrix and bilirubin interference for high-sensitivity cardiac troponin I

(2015) Janet Simons et al.   CLINICA CHIMICA ACTA

Biomarkers for Predicting Serious Cardiac Outcomes at 72 Hours in Patients Presenting Early after Chest Pain Onset with Symptoms of Acute Coronary Syndromes

(2011) P. A. Kavsak et al.   CLINICAL CHEMISTRY

High-Sensitivity Cardiac Troponin I Measurement for Risk Stratification in a Stable High-Risk Population

(2011) P. A. Kavsak et al.   CLINICAL CHEMISTRY

Analytic and Clinical Utility of a Next-Generation, Highly Sensitive Cardiac Troponin I Assay for Early Detection of Myocardial Injury

(2009) P. A. Kavsak et al.   CLINICAL CHEMISTRY

Short- and Long-Term Risk Stratification Using a Next-Generation, High-Sensitivity Research Cardiac Troponin I (hs-cTnI) Assay in an Emergency Department Chest Pain Population

(2009) P. A. Kavsak et al.   CLINICAL CHEMISTRY